Thomas Ramezani

Thomas Ramezani

Auto-generated profile, based on publicly available information

Thomas Ramezani

Institute of Developmental Biology, University of Cologne, Cologne, Germany

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 August 2017 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
DLDavor Lessel
Davor Lessel
DWDanyi Wu
Danyi Wu
CTCarlos Trujillo
Carlos Trujillo
TRThomas Ramezani
Thomas Ramezani
ILIvana Lessel
Ivana Lessel
CKChristian Kubisch
Christian Kubisch
The tumor suppressor p53, a master regulator of the cellular response to stress, is tightly regulated by the E3 ubiquitin ligase MDM2 via an autoregulatory feedback loop. In addition to its well-established role in tumorigenesis, p53 has also been associated with aging in mice. Several mouse models with aberrantly increased p53 activity display signs of premature aging. However, the relationship between dysfunction of the MDM2/p53 axis and human aging remains elusive. Here, we have identified an antiterminating homozygous germline mutation in MDM2 in a patient affected by a segmental progeroid syndrome. We show that this mutation abrogates MDM2 activity, thereby resulting in enhanced levels and stability of p53. Analysis of the patient’s primary cells, genome-edited cells, and in vitro and in vivo analyses confirmed the MDM2 mutation’s aberrant regulation of p53 activity. Functional data from a zebrafish model further demonstrated that mutant Mdm2 was unable to rescue a p53-induced apoptotic phenotype. Altogether, our findings indicate that mutant MDM2 is a likely driver of the observed segmental form of progeria.

1 January 2016 in Development
Verified
Journal Article
Open access
PDF file
RRRebecca Richardson
Rebecca Richardson
MMManuel Metzger
Manuel Metzger
PKPhilipp Knyphausen
Philipp Knyphausen
TRThomas Ramezani
Thomas Ramezani
KSKrasimir Slanchev
Krasimir Slanchev
Matthias HammerschmidtMatthias Hammerschmidt
Matthias Hammerschmidt
Re-epithelialization of cutaneous wounds in adult mammals takes days to complete and relies on numerous signalling cues and multiple overlapping cellular processes that take place both within the epidermis and in other participating tissues. Re-epithelialization of partial- or full-thickness skin wounds of adult zebrafish, however, is extremely rapid and largely independent of the other processes of wound healing. Live imaging after treatment with transgene-encoded or chemical inhibitors reveals that re-epithelializing keratinocytes repopulate wounds by TGFβ- and integrin-dependent lamellipodial crawling at the leading edges of the epidermal tongue. In addition, re-epithelialization requires long-range Rho kinase-, JNK- and, to some extent, planar cell polarity-dependent epithelial rearrangements within the following epidermis, involving radial intercalations, flattening and directed elongations of cells. These rearrangements lead to a massive recruitment of keratinocytes from the adjacent epidermis and make re-epithelialization independent of keratinocyte proliferation and the mitogenic effect of FGF signalling, which are only required after wound closure, allowing the epidermis outside the wound to re-establish its normal thickness. Together these results demonstrate that the adult zebrafish is a valuable in-vivo model for studying, and visualizing, the processes involved in cutaneous wound closure, facilitating the dissection of direct from indirect, and motogenic from mitogenic effects of genes and molecules affecting wound re-epithelialization.

22 July 2016 in Nature Communications
Verified
Journal Article
Open access
FFFrederik Faden
Frederik Faden
TRThomas Ramezani
Thomas Ramezani
SMStefan Mielke
Stefan Mielke
IAIsabel Almudi
Isabel Almudi
KNKnud Nairz
Knud Nairz
NDNico Dissmeyer
Nico Dissmeyer
Phenotypes on-demand generated by controlling activation and accumulation of proteins of interest are invaluable tools to analyse and engineer biological processes. While temperature-sensitive alleles are frequently used as conditional mutants in microorganisms, they are usually difficult to identify in multicellular species. Here we present a versatile and transferable, genetically stable system based on a low-temperature-controlled N-terminal degradation signal (lt-degron) that allows reversible and switch-like tuning of protein levels under physiological conditions in vivo. Thereby, developmental effects can be triggered and phenotypes on demand generated. The lt-degron was established to produce conditional and cell-type-specific phenotypes and is generally applicable in a wide range of organisms, from eukaryotic microorganisms to plants and poikilothermic animals. We have successfully applied this system to control the abundance and function of transcription factors and different enzymes by tunable protein accumulation.

9 January 2014 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
BFBoris Fischer
Boris Fischer
MMManuel Metzger
Manuel Metzger
RRRebecca Richardson
Rebecca Richardson
PKPhilipp Knyphausen
Philipp Knyphausen
TRThomas Ramezani
Thomas Ramezani
Matthias HammerschmidtMatthias Hammerschmidt
Matthias Hammerschmidt
P63 is a multi-isoform member of the p53 family of transcription factors. There is compelling genetic evidence that ΔNp63 isoforms are needed for keratinocyte proliferation and stemness in the developing vertebrate epidermis. However, the role of TAp63 isoforms is not fully understood, and TAp63 knockout mice display normal epidermal development. Here, we show that zebrafish mutants specifically lacking TAp63 isoforms, or p53, display compromised development of breeding tubercles, epidermal appendages which according to our analyses display more advanced stratification and keratinization than regular epidermis, including continuous desquamation and renewal of superficial cells by derivatives of basal keratinocytes. Defects are further enhanced in TAp63/p53 double mutants, pointing to partially redundant roles of the two related factors. Molecular analyses, treatments with chemical inhibitors and epistasis studies further reveal the existence of a linear TAp63/p53->Notch->caspase 3 pathway required both for enhanced proliferation of keratinocytes at the base of the tubercles and their subsequent differentiation in upper layers. Together, these studies identify the zebrafish breeding tubercles as specific epidermal structures sharing crucial features with the cornified mammalian epidermis. In addition, they unravel essential roles of TAp63 and p53 to promote both keratinocyte proliferation and their terminal differentiation by promoting Notch signalling and caspase 3 activity, ensuring formation and proper homeostasis of this self-renewing stratified epithelium. The mammalian epidermis is a stratified self-renewing epithelium, in which cell loss at the surface is properly balanced by cell proliferation in basal layers to ensure tissue homeostasis. But how is this balance genetically controlled? Here, we address this question in zebrafish breeding tubercles, epidermal appendages in which keratinocytes undergo more advanced differentiation processes than in regular fish epidermis, sharing crucial features with the cornified mammalian skin. We identify a linear pathway consisting of the transcription factor p53 and its close relative TAp63, which activate Notch signalling and thereby caspase 3 to promote terminal differentiation and eventual shedding of keratinocytes in upper tubercle layers, while at the same time employing non-cell autonomous mechanisms to promote keratinocyte proliferation at the tubercle base, thereby ensuring proper development and homeostasis of this self-renewing tissue. Such a two-fold function of the pathway is consistent with the formerly reported dual role of a caspase during wing regeneration in the fruitfly. Our findings will help to better understand the seemingly contrary effects described for TAp63 in different mammalian systems, while demonstrating partial functional redundancy between p53 and TAp63 during epidermal development in fish.

25 February 2016 in Chemical Communications
Verified
Journal Article
Open access
PDF file
LZLiyun Zhang
Liyun Zhang
JEJun Cheng Er
Jun Cheng Er
HJHao Jiang
Hao Jiang
XLXin Li
Xin Li
ZLZhaofeng Luo
Zhaofeng Luo
MVMarc Vendrell
Marc Vendrell
Copper/zinc superoxide dismutase (Cu/Zn SOD) is an essential enzyme that protects tissue from oxidative damage. Herein we report the first fluorogenic probe (SODO) for the detection and in vivo imaging of Cu/Zn SOD. SODO represents a unique chemical probe for translational imaging studies of Cu/Zn SOD in inflammatory disorders.

16 July 2025 in Liver International
Verified
Journal Article
Open access
YKYestle Kim
Yestle Kim
PRPeter Rydqvist
Peter Rydqvist
TRThomas Ramezani
Thomas Ramezani
JHJennifer S. Haas
Jennifer S. Haas
HBHeike Bantel
Heike Bantel
Frank TackeFrank Tacke
Frank Tacke
Background: Metabolic dysfunction–associated steatotic liver disease (MASLD) is a major cause of chronic liver disease. Metabolic dysfunction‐associated steatohepatitis (MASH), a progressive form of MASLD, can lead to fibrosis and cirrhosis. The incidence and burden of MASH in Germany are expected to double by 2030, while diagnostic and management challenges persist. Expert consensus on diagnostic strategies and treatment modalities in MASLD and MASH is required.Objectives: The panel aimed to gather insights and consensus on the diagnostic pathway and current treatment modalities for MASH in Germany.Methods: A three‐round web‐based survey, integrating Delphi panel methodology with a standard survey, was conducted from February to May 2024 to reach consensus on predefined questions. The survey involved 12 gastroenterology, diabetology and/or hepatology specialists in Germany.Results: The Delphi panel revealed that ~75% of MASH patients in Germany remain undiagnosed. Non‐invasive measures, such as fibrosis scores (values from clinical and imaging tests to assess fibrosis), liver enzyme tests and liver stiffness measurement, were primary methods for diagnosing and monitoring MASH patients. Lifestyle modifications were the primary management strategy, given the absence of approved pharmacological treatments for MASH. The panel also highlighted significant challenges in managing MASH, including the lack of approved medications and the difficulty in sustaining lifestyle changes.Conclusions: The survey underscores the substantial underdiagnosis of MASH and the reliance on non‐invasive diagnostic methods in Germany. The lack of approved treatments necessitates a focus on lifestyle modifications and comorbidity management. The Delphi panel's insights call for enhanced screening, early detection and standardised algorithms to improve patient outcomes.